Profile data is unavailable for this security.
About the company
ASKA Pharmaceutical Holdings Co Ltd is a Japan-based company mainly engaged in the pharmaceutical business. The Company mainly operates in two business segments. The Pharmaceutical segment is mainly engaged in the manufacture, purchase and sale of pharmaceutical products. The Others segment is involved in the manufacture of veterinary drugs, the provision of clinical testing services, the outsourcing of testing services, the purchase and sale of medical equipment, as well as the sale of health foods.
- Revenue in JPY (TTM)63.57bn
- Net income in JPY5.98bn
- Incorporated2021
- Employees762.00
- LocationASKA Pharmaceutical Holdings Co Ltd2-5-1, ShibauraMINATO-KU 108-8532JapanJPN
- Phone+81 354848845
- Fax+81 354848351
- Websitehttps://www.aska-pharma-hd.co.jp/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Daito Pharmaceutical Co Ltd | 47.40bn | 3.23bn | 33.15bn | 1.07k | 10.42 | 0.6352 | 4.83 | 0.6995 | 207.36 | 207.36 | 3,045.21 | 3,400.43 | 0.6178 | 1.86 | 2.76 | 44,294,390.00 | 3.90 | 6.27 | 5.08 | 8.24 | 20.28 | 22.65 | 6.32 | 8.47 | 1.29 | -- | 0.1891 | 19.59 | 3.98 | 2.66 | -8.47 | -1.27 | 11.37 | 11.67 |
| Fuji Pharma Co Ltd | 46.14bn | 6.15bn | 35.22bn | 1.62k | 5.63 | 0.7594 | 3.58 | 0.7635 | 252.85 | 252.85 | 1,898.01 | 1,873.95 | 0.5263 | 1.51 | 3.04 | -- | 7.01 | 4.64 | 11.20 | 6.63 | 38.68 | 41.29 | 13.33 | 8.83 | 0.6834 | -- | 0.391 | 26.14 | 12.84 | 4.93 | 78.98 | 15.73 | 5.89 | 7.94 |
| Cuorips Inc | 19.22m | -770.78m | 45.60bn | 59.00 | -- | 8.15 | -- | 2,372.14 | -102.64 | -102.64 | 2.59 | 696.57 | 0.0032 | 0.83 | 11.65 | 325,813.60 | -12.67 | -- | -13.03 | -- | 56.90 | -- | -4,011.54 | -- | 36.15 | -14.12 | 0.00 | -- | -39.65 | -- | -39.84 | -- | -- | -- |
| Seikagaku Corp | 38.36bn | 2.02bn | 46.42bn | 988.00 | 22.12 | 0.5923 | 11.98 | 1.21 | 36.93 | 36.93 | 703.07 | 1,379.48 | 0.4679 | 1.93 | 4.88 | 38,827,940.00 | 2.46 | 0.4261 | 2.66 | 0.4678 | 47.98 | 54.18 | 5.25 | 0.9814 | 4.53 | -- | 0.0051 | 465.78 | 8.24 | 4.99 | -2.24 | -0.5224 | 30.28 | 0.00 |
| ASKA Pharmaceutical Holdings Co Ltd | 63.57bn | 5.98bn | 62.23bn | 762.00 | 9.65 | 0.8996 | 7.47 | 0.9789 | 210.94 | 210.94 | 2,243.73 | 2,263.17 | 0.7056 | 1.64 | 3.86 | 83,419,940.00 | 6.63 | 4.63 | 8.44 | 5.87 | 49.38 | 46.94 | 9.40 | 6.76 | 1.71 | -- | 0.1064 | 14.86 | 3.94 | 6.12 | 78.03 | 34.04 | -37.89 | 23.36 |
| Katakura Industries Co., Ltd. | 38.12bn | 2.89bn | 71.10bn | 1.04k | 22.96 | 0.8565 | 12.33 | 1.87 | 87.92 | 87.92 | 1,158.05 | 2,357.16 | 0.2725 | 1.99 | 5.37 | 36,650,960.00 | 2.17 | 2.35 | 2.79 | 3.34 | 38.62 | 37.75 | 7.97 | 8.32 | 2.56 | -- | 0.1026 | 18.81 | 16.62 | -2.04 | 8.09 | 18.87 | -7.46 | 10.76 |
| JCR Pharmaceuticals Co Ltd | 35.26bn | -437.00m | 90.26bn | 934.00 | -- | 1.54 | 28.87 | 2.56 | -3.49 | -3.49 | 281.91 | 451.84 | 0.338 | 0.4791 | 2.15 | 37,747,320.00 | -0.3864 | 8.66 | -0.5681 | 13.46 | 71.44 | 74.51 | -1.14 | 18.24 | 0.9827 | -0.3874 | 0.3325 | 30.60 | 24.83 | 13.11 | 46.00 | 8.19 | 18.54 | 21.67 |
Data as of Nov 22 2024. Currency figures normalised to ASKA Pharmaceutical Holdings Co Ltd's reporting currency: Japanese Yen JPY
15.81%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Dalton Investments, Inc.as of 30 Oct 2024 | 1.57m | 5.14% |
| The Vanguard Group, Inc.as of 06 Nov 2024 | 687.59k | 2.25% |
| Dimensional Fund Advisors LPas of 07 Nov 2024 | 669.24k | 2.19% |
| Nomura Asset Management Co., Ltd.as of 07 Nov 2024 | 558.50k | 1.83% |
| Amundi Japan Ltd.as of 20 Feb 2024 | 492.01k | 1.61% |
| Nikko Asset Management Co., Ltd.as of 08 Nov 2024 | 325.30k | 1.06% |
| Daiwa Asset Management Co. Ltd.as of 31 Oct 2024 | 253.60k | 0.83% |
| Mitsubishi UFJ Asset Management Co., Ltd.as of 07 Nov 2024 | 119.70k | 0.39% |
| Norges Bank Investment Managementas of 30 Jun 2024 | 97.40k | 0.32% |
| Asset Management One Co., Ltd.as of 07 Nov 2024 | 58.10k | 0.19% |
More ▼
Data from 30 Jun 2024 - 30 Sep 2024Source: FactSet Research Systems Inc.
